Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / KT - South Korea's KT Hanmi invest in digital therapy-focused Digital Pharm

KT - South Korea's KT Hanmi invest in digital therapy-focused Digital Pharm

KT Corporation
South Korean companies KT (NYSE:KT) and Hanmi Pharmaceutical said they co-invested in Digital Pharm, a company specializing in digital therapeutics (DTx) and electroceuticals. Telecom company KT said Digital Pharm is a subsidiary of Catholic University of Korea Technology Holding Company, which was founded in November 2021 by Kim Dai-jin of Catholic University’s Seoul St. Mary's Hospital. KT added that in the future it plans to develop a digital treatment platform, set up business strategies for the new company, and build a pipeline of digital treatment devices and electroceuticals. Meanwhile, Hanmi will establish digital therapies B2H (business to hospital) and sales and marketing strategies. The companies also intend to drive additional value through strategic licenses. Digital Pharm's ongoing business will be to discover new DTx pipelines and the it is scheduled to start a confirmatory clinical trial in H2 2022 for an addiction-related digital therapy e-medication for alcohol and nicotine. In addition, Digital

For further details see:

South Korea's KT, Hanmi invest in digital therapy-focused Digital Pharm
Stock Information
Company Name: KT Corporation
Stock Symbol: KT
Market: NYSE
Menu
KT KT Quote KT Short KT News KT Articles KT Message Board
Get KT Alerts

News, Short Squeeze, Breakout and More Instantly...